Synthesis and Characterization of Impurities of a Common and Advanced Intermediate of Candesartan and Azilsartan Antihypertensive Drugs
Sangeeta Sangwan, Tapas Panda, Kaushal Nayyar, Sharwan K. Dewan, Rajesh K. Thaper
International Research Journal of Pure and Applied Chemistry · pp. 140–149 · Published 6 Nov 2014
10.9734/IRJPAC/2015/13162Abstract
Six impurities were identified in the lab development batches during the course of benzimidazole intermediate (1) synthesis by reverse phase HPLC method. Intermediate 1 is used as a common and advanced intermediate in the synthesis of candesartan and azilsartan. All the impurities were characterized by IR, NMR, LC/MS and CHN analyses, which included an isomer of intermediate 11 (impurity 19), desethyl analogue of 1 (impurity 20), desethoxy analogue of 1 (impurity 21), methyl analogue of 1 (impurity 22), cyanobiphenyl benzimidazole (impurity 25) and cyanobiphenyl derivative of 1 (impurity 26). The synthesis and characterization of these impurities are presented.
References (13)
- 1 Angiotensin Receptors and Their Antagonists [DOI]
- 2 Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids [DOI]
- 3 Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids [DOI]
- 4 Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles [DOI]
- 5 One-Pot Synthesis of 1H-Benzimidazole Derivatives Using Thiamine Hydrochloride as a Reusable Organocatalyst [DOI]
- 6 LC and LC–MS/TOF studies on stress degradation behaviour of candesartan cilexetil [DOI]
- 7 Hydrolysis and transesterification reactions of candesartan cilexetil observed during the solid phase extraction procedure [DOI]
- 8 Improved Process for Azilsartan Medoxomil: A New Angiotensin Receptor Blocker [DOI]
- 9 A novel and practical synthesis of substituted 2-ethoxy benzimidazole: candesartan cilexetil [DOI]
- 10 Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116). [DOI]
- 11 Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR [DOI]
- 12 Synthesis of Azilsartan and Its Selected Potential Impurities [DOI]
- 13 Identification, synthesis and structural determination of some impurities of candesartan cilexetil [DOI]
Cited by 6
Chandramohan Alluri, Kiran Kumar Naramsetti, G. Veera Raghava Sharma · Journal of Pharmaceutical Research International · 2021
N. V. D. Harikiran Maddi, Srinivas Garaga, Ambati V. Raghava Reddy · Current Issues in Pharmacy and Medical Sciences · 2017
Ana Testen, Miha Plevnik, Bogdan Štefane · Acta Pharmaceutica · 2018
Showing 3 of 6 known citations — external sources report more than can currently be individually listed.
Related research
- Synthesis of 2-Substituted Benzimidazole Derivatives as a Platform for the Development of UV Filters and Radical Scavengers in Sunscreens — shares topic coverage
- Dichloro-Bis(1-Alkyl/Styryl-Benzimidazole)-Cobalt(II) Pre-Catalyst for Ethylene Dimerization — shares topic coverage
- Evaluation of Biological Activity of Some Benzimidazole Derivatives as Antifungal — shares topic coverage
- Facile Synthesis and Characterization of New 2,3-Disubstituted Benzimidazole Derivatives — shares topic coverage
- Biologic Activity of Novel Benzimidazolone Acetamide Derivatives: In vitro Evaluation against Six Bacterial Strains — shares topic coverage
Article metrics
Real usage data collected on this platform.
34
Page views
0
PDF downloads
9
Outbound clicks
6
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.